We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Rhi Magnesita N.v. | RHIM | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
3,130.00 | 3,070.00 | 3,135.00 | 3,105.00 | 3,150.00 |
Industry Sector |
---|
INDUSTRIAL METALS |
Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
---|---|---|---|---|---|---|
28/02/2024 | Final | EUR | 1.25 | 16/05/2024 | 17/05/2024 | 13/06/2024 |
26/07/2023 | Interim | EUR | 0.55 | 24/08/2023 | 25/08/2023 | 22/09/2023 |
27/02/2023 | Final | EUR | 1.1 | 08/06/2023 | 09/06/2023 | 06/07/2023 |
01/08/2022 | Interim | EUR | 0.5 | 25/08/2022 | 26/08/2022 | 23/09/2022 |
28/02/2022 | Final | EUR | 1 | 26/05/2022 | 27/05/2022 | 14/06/2022 |
28/07/2021 | Interim | EUR | 0.5 | 26/08/2021 | 27/08/2021 | 14/09/2021 |
08/03/2021 | Final | EUR | 1 | 10/06/2021 | 11/06/2021 | 30/06/2021 |
Final | EUR | 0.5 | 03/12/2020 | 04/12/2020 | 21/12/2020 | |
12/08/2019 | Interim | EUR | 0.5 | 19/12/2019 | 20/12/2019 | 09/01/2020 |
Top Posts |
---|
Posted at 03/1/2024 13:08 by arja market looks oversold and especially RHIM and surely a good day trading opportunity assuming the DOW and US indices do not tank after 2.30pm . If so, seems s low risk trade to say the least |
Posted at 09/8/2023 16:13 by vb6 My tendered RHIM shares are still sitting in my account. Am I to assume that they are to remain mine despite the corporate action? |
Posted at 30/5/2023 16:31 by typo56 It was in an RNS at 07:32, just not tagged to RHIM |
Posted at 30/5/2023 08:32 by typo56 Ignite Luxembourg Holdings, a company indirectly managed by Rhone Holdings VI, offered to buy a 20% stake in RHI Magnesita at GBP28.5 per share in cash, a 39% premium to the stock's close on Friday. Rhone said it aims to buy a non-controlling minority stake in Vienna-based supplier of refractory products. The offer values all of RHI Magnesita at GBP1.34 billion, or at GBP1.38 billion including a dividend recently declared by RHI Magnesita. |
Posted at 13/1/2023 23:30 by daemonfunds Acquisition of Jinan New Emei announced today, with RHIM paying 293mio yuan for 65% of pre-tax income of 33 mio yuan (some of the cost of this part of the acquisition is deferred, and the full purchase of the remainder is dependent on Jinan meeting hurdles). The numbers imply a 450mio yuan purchase price for 100% of the company down the line, where total assets are 829mio yuan. Take that with a grain of salt as we are talking about a Chinese company - make it 700mio yuan gross assets. Implies a price to total assets of 0.65x - RHIM's own total assets were last reported at 3.914bio eur, implying a target market cap of 2.544bio eur. Given Jinan's last year's pre-tax income, the purchase price implies a multiple of 13.65x - applying to RHIM's own last reported 2021 FY annual pre-tax income is unrealistic so we'll apply to it a lower 200mio eur, giving 2.73bio eur. We can see where RHIM value themselves. So where are we now - mkt cap today at 1.16bio gbp or 1.31bio eur. Total debt at 1.6bio eur (assuming they need all their cash to fund operations, maintenance capex, etc.). EV is 2.9bio eur. Average EBITDA has been about 350mio eur over last few years (thanks Morningstar), while capex has ramped up destroying FCF. EV/EBITDA just over 8.25x. Total debt looks high at 4x leverage on unaadjusted basis, though seems interest rates are locked in for a few more years. Fragmented industry with acquisition potential as recession and higher interest rates expected over next two years squeeze the competition. Assume they maintain their growth at 5% as they acquire, gain market share through competitive advantages (lower costs, software integration at clients, etc.). If margins stay where they are (15% EBITDA given about 5% annual depreciation), end 2024 numbers (they are just about to report end 2022) could be looking at 3bio eur revenue, with 450mio eur EBITDA, which at same EV/EBITDA as today gives 3.73bio eur EV, less 1.73bio eur debt (assume some movement towards management's target leverage ratio and some take on to fund acquisitions), gives ~2bio eur potential mkt cap - about a 25% CAGR from where we are at the moment. so with no movement in valuation multiples, not counting dividends, assuming management can leverage prime position in a fragmented industry (organic market share gains as recently demonstrated, as well as acquisitions of distressed competitors), the company could be on their way to where their Jinan acquisition multiples imply in early 2025. What's the downside risks? Debt management is misjudged as we enter into a severe recession and they are forced into bankruptcy and a fire sale of assets? If so, as at end 2021 reported numbers - cash = 580, inventories 976*75%, trade and other receivables 568*50%, PPE 1089*75% = 2412mio eur, less 1.6bio eur total debt = 800mio eur versus 1.31bio eur market cap. 500 downside versus 700 upside. the downside is quite extreme while the upside is only a little optimistic (IMO) so let's give the upside a two thirds probability. Full Kelly would tell you to put ~40% of your portfolio in it. Key acronym? IMO... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions